Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Somerset Therapeutics LLC recalls Dexamethasone Sodium Phosphate Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.
Products
  • Dexamethasone Sodium Phosphate Injection
Where it was sold

Nationwide in the USA

Nationwide

Units affected
62190 vials
About this recall
Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873, NDC carton: 70069-025-10; NDC vial: 70069-025-01